All patients were administered intranasal budesonide for 12 months. Patients were evaluated for nasal symptoms, polyp size and quality of life. At 6 and 12 months, a significant improvement in all ...

Bronchial budesonide inhibits the seasonal increase in nasal and blood eosinophils, and nasal lavage levels of ECP. [102] These observations should be kept in consideration, as the distant effects ...

A new priority research paper, featured as the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 22, was published on December 29 ...

There was no effect of insulin in the larger cohort using the second device. In a subsequent Phase 2 study to determine how much insulin entered the brain after nasal delivery, 19 people received 40 ...